Document ID: chunk:federal_register_of_legislation:F2023L01751:schedule:1
Version: federal_register_of_legislation:F2023L01751
Segment Type: schedule
Provision Reference: sch 1
Character Range: 2072–2868

Schedule 1—Amendments

National Health (Price and Special Patient Contribution) Determination 2022 (PB 98 of 2022)

        1. Schedule 1 – entry for Glimepiride
Omit
Glimepiride  Tablet 1 mg  Oral  Amaryl  30  2.50  4.58
             Tablet 2 mg  Oral  Amaryl  30  2.50  4.53
             Tablet 3 mg  Oral  Amaryl  30  2.69  4.72

            Insert
Glimepiride  Tablet 1 mg  Oral  Amaryl  30  2.50  4.58
             Tablet 2 mg  Oral  Amaryl  30  2.50  4.53

       2.                 Schedule 1 – entry for Ondansetron
Omit
Ondansetron  Wafer 4 mg  Oral  Zofran Zydis  10  8.75  11.04
             Wafer 8 mg  Oral  Zofran Zydis  10  5.35  15.66

     Insert
Ondansetron  Wafer 4 mg  Oral  Zofran Zydis  10  8.75   11.04
             Wafer 8 mg  Oral  Zofran Zydis  10  13.38  15.66